European Union Pharmaceutical Markets: A Case for Differential Pricing?
نویسندگان
چکیده
منابع مشابه
Parallel imports and the pricing of pharmaceutical products: evidence from the European Union.
We consider policy issues regarding parallel imports (PIs) of brand-name pharmaceuticals in the European Union, where such trade is permitted. We develop a simple model in which an original manufacturer competes in its home market with PI firms. The model suggests that for small trade costs the original manufacturer will accommodate the import decisions of parallel traders and that the price in...
متن کاملComparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
AIM To perform a comparative analysis of the pharmaceutical pricing and reimbursement systems in Croatia and the 27 European Union (EU) Member States. METHODS Knowledge about the pharmaceutical systems in Croatia and the 27 EU Member States was acquired by literature review and primary research with stakeholders. RESULTS Pharmaceutical prices are controlled at all levels in Croatia, which i...
متن کاملPricing European Options in Realistic Markets
We investigate the relation between the fair price for European-style vanilla options and the probability of short-term returns on the underlying asset in the absence of transaction costs. If the asset’s future price has finite expectation, the option’s fair value satisfies a parabolic partial differential equation of the Black-Scholes type in the absence of arbitrage opportunities. However, th...
متن کاملHigher Education Internationalization in European Union
Background: Nowadays, the wordwide trend for becoming most competitive and the most dynamic knowledge based economy is the responsibility of universities. The European Union is moving in this direction for global competitiveness, the retrieval process and brain circulation and income generation. This study, aimed to evaluate the internationalization trend of higher education in Europe. Me...
متن کاملComparative approaches to pharmaceutical price regulation in the European Union.
AIM To review pharmaceutical price regulation methods in countries of the European Union (EU), in terms of the anticipated impact of regulation on pharmaceutical expenditures and evidence of actual outcomes. METHOD An extensive search was performed of medical and economic studies on regulatory interventions specifically targeting pharmaceutical prices in EU countries, published between Januar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of the Economics of Business
سال: 2015
ISSN: 1357-1516,1466-1829
DOI: 10.1080/13571516.2015.1045747